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a b s t r a c t
The link between trace elements imbalances (both “toxic” and “essential”) in the human brain and neurodegenerative disease has been subject 
of extensive research. More recently, some studies have highlighted the potential role of the homeostasis deregulation of alkali metals in 
specific brain regions as key factor in the pathogenesis of neurodegenerative diseases such as multiple sclerosis and Alzheimer’s disease.
Using flame atomic emission spectrometry and inductively coupled plasma-mass spectrometry after microwave-assisted acid digestion of 
the samples, alkali metals (Na, K, Li, Rb and Cs) were determined in 14 different areas of the human brain (frontal cortex, superior and middle 
temporal gyri, caudate nucleus, putamen, globus pallidus, cingulated gyrus, hippocampus, inferior parietal lobule, visual cortex of the occipital 
lobe, midbrain, pons, medulla and cerebellum) of adult individuals (n = 42; 71 ± 12, range: 50–101 years old) with no known history and 
evidence of neurodegenerative, neurological or psychiatric disorder.
Potassium was found as the most abundant alkali metal, followed by Na, Rb, Cs and Li. Lithium, K and Cs distribution showed to be quite 
heterogeneous. On the contrary, Rb and Na appeared quite homoge-neously distributed within the human brain tissue. The lowest levels of 
Na, K, Rb and Li were found in the brainstem (midbrain, medulla and pons) and cerebellum, while the lowest levels of Cs were found in the 
frontal cortex. The highest levels of K (mean ± sd; range 15.5 ± 2.5; 8.9–21.8 mg/g) Rb (17.2 ± 6.1; 3.9–32.4 g/g and Cs (83.4 ± 48.6; 17.3–220.5 
ng/g) were found in putamen. The highest levels of Na and Li were found in the frontal cortex (11.6 ± 2.4; 6.6–17.1 mg/g) and caudate nucleus (7.6 
± 4.6 2.2–21.3 ng/g), respectively.Keywords: Human brain;Alkalimetals; Postmortem analysis; Ageing
Although K, Cs and Li levels appear to remain largely unchanged with age, some age-related changes were observed for Na and Rb levels in 
particular brain regions (namely in the hippocampus).IntroductionNeurodegenerative diseases (ND), such as Alzheimer’s and Park
s assumed that they involve a complex interaction between (natu-ral) ageing, and ge
ole for oxidative stress [4–6] and some dis-turbances in transition metals levels (e.g.
nd K) have also been associated with some ND [9,10].
Potassium and Na are the most important cations of intra and extrac
phys-inson’s diseases, are chronic multifactorial diseases and it 
netic and environmental factors [1–3]. Growing evidence indicates a 
, Fe, Cu, Zn) [7,8]. More recently, imbalances in alkali metals levels (Na 
ellular fluids, respectively, playing a major role in many 
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cological processes, such as electric impulse conduction in excitable
ells (e.g., neurons, cardiac cells) [11,12]. The concentration of these
lectrolytes is maintained by the Na+/K+-ATPase pump and imbal-
nces of Na and K concentration in the extracellular fluid cause the
ovement ofwater into or out of the cells, altering the intracellular
uid osmotic pressure and causing cells swelling or shrinkage [13].
smotic shifts affect all cells and tissues but the brain is particularly
usceptible to damage from changes in intracranial pressure [11].
Although Li does not have a known biological role and does not
ppear to be an essential element for humans, lithium salts (e.g.,
arbonate, acetate) have been extensively used in the treatment of
anic-depressive disorders for more than 50 years [14]. In the last
wodecades, several studieshave further suggested that Limayalso
ave neuroprotective effects against amyotrophic lateral sclerosis,
nd Alzheimer’s and Parkinson’s diseases [15].
Rubidium and Cs are also regarded as non-essential elements
or humans and have no known biological role. In many animals,
ncluding humans, the distribution of both Rb and Cs resembles
hat of K and it has been shown that Rb and, to a lesser extent,
s can replace K as an essential nutrient for the growth of bacte-
ia, yeast and rats [16]. Although generally less readily transported,
s has been shown to compete with K and Rb for both active and
assive membrane transport due to their similar physicochemical
roperties [17].
It must be highlighted that the brain is a highly heterogeneous
rgan, with anatomically and physiologically very different areas,
hich may be affected in different manners by the ageing and neu-
odegenerative processes [18]. So, as a first step, a detailed study of
he anatomical distribution of alkali metals in the “normal” brain is
ndispensable to clarify their role both in the normal human brain
hysiology and neurodegenerative diseases. To date, alkali metals
K, Na, Rb, Li and Cs) have been a poorly studied and data on their
opographical distribution in the human brain are scarce, mostly
imited to a fewbrain regions, to largeornot specifiedbrain regions,
nd/or involving a reduced number of subjects [19–22].
Based on this background, the main goal of the present study
as to contribute to the establishment of reference levels for alkali
etals in the different anatomical and functional regions of “nor-
al”humanbrain.WedirectlydeterminedNa,K,Rb, Cs andLi levels
n postmortem human brain tissue in order to evaluate: (a) the
egional anatomic differences across the brain and (b) their change
n relation to age.
Materials and methods
ubjects
Brain samples were obtained from men (n=27; 67±11years
ld) and women (n=15; 77±12 years old) not registered in the
ortuguese National Registry of Refusal to Organ Donation database
nd complying with all the current regulations regarding human
issue collection for scientific research purposes.
Samples were collected from individuals submitted to foren-
ic autopsy during the first semester of 2012 at the North Branch
Porto) of the Portuguese National Institute of Legal Medicine and
orensic Science (INMLCF). Individuals from each of the follow-
ng age groups were studied: 50–59 (n=10), 60–69 (n=10), 70–79
n=10), 80–89 (n=9) and ≥90 (n=3) years old. Inclusion criteria
ere: (a) absence of known neurodegenerative, neurological or
sychiatric disorder history; (b) absence of injuries involving CNS;
c) macroscopically normal brain tissue.Samples from two individuals with documented Alzheimer’s
isease (women, 73 and 85 years old) and one individual with
ocumented Parkinson’s disease (woman, 91 years old) were also
ollected and results are also presented.Sample collection
Samples were collected by INMLCF pathologists following a
standard protocol. In order to prevent sample contamination, all
materials contacting with the samples, including the stainless
steel dissection tools, were previously decontaminated with 5%
(v/v) nitric acid solution (prepared from concentrated HNO3 ≥69%;
Sigma-Aldrich, Germany) and thoroughly rinsed with ultrapure
water (resistivity >18.2M cm at 25 ◦C), produced by an arium®
pro (Sartorius, USA) water purification system.
After removing the brain from the cranium, the excess of blood
was thoroughly washed with ultrapure water. Meninges were
removed with plastic tweezers and the brain tissue was washed
again with ultrapure water to minimize samples contamination
with blood or cerebrospinal fluid.
In order to establish an accurate diagnosis and study the
relationship between the disease process and either the clinical
features seen in life or the cause of death, Paine and Lowe [18]
have proposed a post-mortem approach where 14 key brain areas
should be studied individually (Fig. 1). Using decontaminated plas-
tic knives, tissue fragments (approximately 1 cm3) were collected
from the following brain areas: frontal cortex (1), superior (2A) and
middle (2B) temporal gyri, caudate nucleus (3A), putamen (3B),
globuspallidus (3C), cingulated gyrus (4), hippocampus (5), inferior
parietal lobule (6), visual cortex of the occipital lobe (7), mid-
brain (including the substantia nigra at the level of the third nerve)
(8), pons-locus coeruleus (9),medulla (10) and cerebellum-dentate
nucleus (11). Samples were stored in decontaminated polypropy-
lene tubes (Sarstedt, Germany) at −4 ◦C until analysis.
Sample pre-treatment
After thawing, brain samples were thoroughly washed with
ultrapure water and placed in a dry oven (Raypa, Spain) at 110 ◦C
until constant weight (ca. 24h). Dried samples (ca. 100–500mg)
were weighed directly in the microwave digestion vessels previ-
ouslywashedwith10% (v/v)HNO3 and rinsedwithultrapurewater.
Samples were digested with 2.5mL of HNO3 ≥65% and 1.0mL of
H2O2 ≥30% (both TraceSELECT® Ultra, Sigma-Aldrich, France). The
digestion was performed in a MLS-1200 mega microwave oven
(Milestone, Italy), equipped with a HPR 1000/10 rotor, using the
following power (W)/time (min) program: 250/1, 0/2, 250/5, 400/5
and 600/5. After cooling, samples digests were made up to 50mL
with ultrapure water and stored in closed propylene tubes at 4 ◦C
until analysis.
Potassium and sodium determination
Determination of K and Na was performed by flame atomic
emission spectrometry (FAES), using a PerkinElmer (Germany)
Model 3100 instrument according to the standard conditions rec-
ommended by themanufacturer (air/acetylene flame; K: 766.5nm,
slit 0.7nm; Na: 589.0nm, slit 0.2nm).
Calibration curves were obtained with five standard solutions
with concentrations ranging from 0.2 to 1.0mg/L for Na and
0.4–2.0mg/L for K, prepared by adequate dilution of 1000mg/L
single element commercial standard solutions (Sigma-Aldrich,
Switzerland) with 0.2% v/v HNO3. Sample solutions were also
diluted (100-fold) with 0.2% v/v HNO3. A 1% (w/v) Cs solution, pre-
pared by dissolution of Cs2CO3 (Sigma-Aldrich, France) in ultrapure
water, was added to all samples and calibration standards (final
concentration: 0.1% (w/v)) in order to suppress analytes ionization.
Fig. 1. Sampled brain regions, as suggested by Paine and Lowe [18]: frontal cortex (1), superior (2A) and middle (2B) temporal gyri, basal ganglia including the caudate
nucleus (3A), putamen (3B), globus pallidus (3C), cingulate gyrus (4), hippocampus (5), inferior parietal lobule (6), visual cortex of the occipital lobe (7), midbrain (including
the substantia nigra at the level of the third nerve) (8), pons-locus coeruleus (9), medulla (10), and cerebellum-dentate nucleus (11).
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wig. 2. Distribution of alkali metals according to the brain region. The metal content
o maximum value ratio.
ithium, cesium and rubidium determination
Lithium, Cs and Rb quantification was performed by ICP-MS
sing an iCAP-Q instrument (Thermo Scientific, UK), equippedwith
icroMistTM (Glass Expansion, Australia) type A concentric neb-
lizer, a Peltier-cooled impact-bead spray chamber, a standard
uartz tube torch, and nickel sampling and skimmer cones. Sam-
ling interface was cooled to 20 ◦C by circulating water. For sample
ntroduction, an ASX-520 autosampler (Cetac Technologies, USA)
as used. High-purity argon (BIP, 99.99997%; supplied by Gasin,
ortugal) was used as the nebulizer and plasma gas. The equip-
ent control and data acquisition were made through the Qtegra
oftware (Thermo Scientific). Elemental isotopes (m/z ratios) 9Li,
5Rb and 133Cs were monitored for analytical determinations, and
5Sc, 89Y, 115In and 159Tbweremonitored as internal standards. The
nstrument was daily checked for maximum signal sensitivity and
tability with Tune B iCAP solution (1.0g/L Ba, Bi, Ce, Co, In, Li and
) from Thermo Scientific.
All the solutions were prepared with 2% (v/v) HNO3. Calibration
urves were obtained with seven solutions of element concen-
rations within the 1–100g/L range (Cs range: 0.1–10g/L).
alibration solutions were prepared by adequate dilution of SCP-
3-MS multi-element standard solution (100mg/L, SCP Science,
anada) and a 1000mg/L Cs standard solution (Sigma-Aldrich,
witerzland). An internal standards (Sc, Y, In, Tb, and Bi) solution
TMas prepared by dilution of a commercial solution (AccuTrace
eference Standard, ICP-MS 200.8-IS-1; AccuStandards, USA). It
as added to all samples and standard solutions in order to obtain as of metal/g of dry weight tissue) were “normalized” using the specific region value
10g/L final concentration. Sample solutions were diluted (5-fold)
before analysis.
Analytical quality control
Because human brain tissue is not available as certified ref-
erence material (CRM) for alkali metals determination, DOLT-4
Dogfish Liver CRM for Trace Metals (National Research Council,
Canada), StandardReferenceMaterial 1640TraceElements inNatu-
ralWater (National Instituteof StandardsandTechnology,USA)and
ERM-CA022 Soft Drinking Water UK—Metals (European Reference
Materials, UK) were used for analytical quality control purposes.
DOLT-4 was subjected to the same pre-treatment as brain samples.
For contamination control during the microwave-assisted acid
digestion procedure, a sample blank was performed in each diges-
tion cycle (10 samples). In total, 77 sample blankswere run, and the
mean valuewas subtracted from the sample values. All the samples
solutions, after the adequate dilution, were analyzed in triplicate.
Statistical evaluation
Descriptive statistical parameters (mean and standard devia-
tion) were calculated using Microsoft Office Excel 2013 (Microsoft
Co., USA). Pearson correlation calculation and mean comparisons
(=5%)wereperformedusingStatPlus:macversionv5 (AnalystSoft
Inc., USA).
For statistical calculations, sample values below the detection
limit (DL) were replaced by DL divdided by the square root of 2.
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.Results and discussion
Potassium [mean± sd (range): 12.3±1.2 (8.9–15.4) mg/g dry
eight] was shown to be the most abundant alkali metal in
he human brain, followed by Na [7.6±1.1 (5.7–10.5) mg/g], Rb
12.5±4.1 (2.9–22.5) g/g], Cs [69.2±27.9 (36.0–168.5) ng/g] and
i [4.5±1.6 (2.1–9.0) ng/g].
Inter-individual variability, characterized as the mean of the
ercent relative standard deviation (RSD%) representative of each
egion [22], is higher for non-essential elements Li (60%), Cs (51%)
nd Rb (39%) than for essential elements Na (20%) and K (17%).
aiki et al. [23] reported higher inter-individual variability for Rb
20%) than for Na (18%) and K (11%), and Bélavári et al. [21] found
reater inter-individual variability for Rb (44%) and Cs (30%) than
or K (12%) and Na (10%). This high variability in brain tissue levels
etween individuals for non-essential elements such as Cs and Rb
s probably the result of the different levels of exposure, particu-
arly through the diet, which strongly depends on the geological
haracteristics of the area where the individual lives [21]. More-
ver, homeostatic mechanisms that ensure the maintenance of
rain levels within narrow limits are not expected to exist for these
on-essential elements. Increased measurement errors might also
ave contributed to the higher inter-individual variability of less
bundant metals (Cs and Li).
natomical region differences on alkali metals levels
Results (mean± sd; mass of element per mass of dry tissue)
f alkali metals levels obtained for each of the 14 different brain
egions studied are summarized in Table 1.
Regarding the inter-regional variability (characterized as the
SD% of themean values for each brain region) [22], results showed
hat Li, K and Cs distribution is quite heterogeneous (inter-regional
ariability: 27%, 20%, 17% respectively). As previously referred,
ncreased inaccuracy of Cs and Li measurements might have con-
ributed to the higher inter-regional variability, since these metals
evels were at six order of magnitude lower than Na and K.
For clarity of presentation, data (mass of metal/g of dry weight
issue) were “normalized” using the specific region value to maxi-
um value ratio (Fig. 2).
Regardless of age group, the highest levels of Kwere found in the
iddle temporal gyrus [15.6±1.8 (11.5–19.1) mg/g] and putamen
15.5±2.5 (8.9–21.8) mg/g]. The highest levels of Cs were found
n the putamen [93.0±49.8 (32.6–250.3) ng/g], a brain structure
ainly involved in motor control [24].
The lowest levelsofKandCswere found in themedulla [7.0±1.8
2.8–10.6) mg/g] and frontal cortex [53.4±21.1 (20.1–117.3)
g/g], respectively. The pons [9.8±1.8 (4.4–13.8) ng/g], midbrain
10.2±1.5 (6.7–13.9) ng/g] and cerebellum [10.7±1.4 (8.3–14.3)
g/g] were also regions with low K content. Low levels of Cs were
lso found in the cerebellum [60.2±34.3 (18.2–180.6) ng/g] and
edulla [60.7±25.4 (15.0–155.5) ng/g].
The highest levels of Li were found in the caudate nucleus
7.6±4.6ng/g (2.2–21.3)] and the lowest in the cerebellum
2.9±1.3ng/g (1.1–6.6)].
Rubidium (inter-regional variability: 8%) and Na (15%) seems
o be more homogeneously distributed in the human brain than
he other alkali metals. The highest levels of Rb were found in the
utamen [17.4±6.1 (3.9–32.4)g/g] and the lowest in themedulla
7.9±4.3 (1.5–20.6) g/g]. The highest levels of Na were found in
he frontal cortex [11.6±2.4 (6.6–17.1)mg/g] and the lowest in the
erebellum [4.3±0.8 (2.4–7.9) mg/g].The heterogeneous regional distribution of several major and
race elements in the brain is well known [25] and it has been
ssumed that the distribution pattern is probably related to the
pecific physiological environment and functions of the different Ta
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drain areas. The heterogeneous distribution of elements across the
uman brain may be partly due to differences in cellular density,
ell volumes and cell types between thedifferent brain regions [21].
hile thewhitematter ismainly composed of glial cells andmyeli-
ated axons, the greymatter contains the cell bodies, dendrites and
xon terminals of neurons, so it iswhere all synapses are [26]. Since
a+/K+-ATPase is present in the synaptic membranes [13], higher
evels of alkali metal in regions with higher content of grey matter
an be expected. Except for Na, the highest levels of alkali met-
ls were found in the deep grey matter nuclei, which include the
asal ganglia, a structure comprising caudatenucleus, putamenand
lobus pallidus. The lowest alkali metals levels were found mainly
n the brainstem (pons,medulla,midbrain), regions predominantly
omposed of white matter.
In general, our results regarding alkalimetals distribution across
he brain are in good agreement with previously published data
Table 2). Saiki et al. [23] also reported that Rb (5.4%) is more
omogeneously distributed than K (12.3%) and Na (13.3%). Bélavári
t al. [21] also found a heterogeneous distribution of alkali met-
ls, although they reported that K (9%) is more homogeneously
istributed than Na (22%), Cs (21%) and Rb (18%).
As a result of their chemical similarity and metabolic inter-
hangeability, a correlation would be expected between K and
b and K and Cs. Our results showed a positive correlation (p-
alue <0.001) between K and Rb (r =0.597), Cs and Li (r = 0.452),
b and Cs (r = 0.437) and K and Na (r =0.415). Several authors
ound similar results. Panayi et al. [29] also found a positive cor-
elation for Rb-Cs (p <0.001), K-Rb and K-Cs (p <0.005). Stedman
nd Spyrou [28] found a positive correlation for Na-K (r =0.5448;
<0.01). Bélavári et al. [21] found apositive correlation only for Rb-
s (r = 0.864; p<0.001) and Duflou et al. [25] only for K-Rb (r =0.88;
<0.05). On the other hand, Rajan et al. [19] found a negative cor-
elation between mole% of Na and mole% of K (r =−0.82).
ge-related changes on alkali metals levels
Considering the mean value of the results obtained for the 14
rain regions, a tendency for an age-related increase of Na lev-
ls was found (r =0.37; p=0.02) (Fig. 3a). This positive correlation
as particularly significant in some specific regions, namely in the
ippocampus (r = 0.53; p<0.001) and, although not reaching statis-
ical significance, in the middle temporal gyrus (r = 0.28; p=0.08)
Fig. 3b), two brain regions involved in memory functions [41].
On the other hand, a tendency for an age-related decrease of Rb
evels was found (r =−0.36; p=0.02) (Fig. 4a). Excluding the pons,
here Rb levels remained quite unchanged with age, this negative
orrelation was observed in all regions studied, the most signifi-
ant being the frontal cortex (r =−0.46; p<0.01) and hippocampus
r =−0.41; p=0.01) (Fig. 4b and c).
No age-related changes were found for K, Cs and Li levels in the
4 studied brain regions (Fig. 5).
A limited number of studies evaluating the age-related changes
f alkali metals in human brain are available. Tohno et al. [35] eval-
ated the relationship between age and Na levels in the caudate
ucleus, putamenandglobuspallidus but no correlationwas found.
uflou et al. [25] also did not find any clear correlation between
b levels and age. These authors reported an age-related decline
n K levels but this conclusion was supported on extreme values
btained in two (out of 12) subjects. Hebbrecht et al. [42] studied
ve regions (basal ganglia, cerebral cortex, cerebral white matter,
rainstem and cerebellar cortex) of human brain (n=18 individu-
ls, 7–79 years old) and found an age-related decrease in Rb and K
evels in thebasal ganglia and cerebralwhitematter. An age-related
ecrease was also found for Rb in the other three areas studied.Gender-related differences on alkali metals levels and the 
effect of smoking habits
Considering themeanmetal levels (i.e., themeanvalue for the14
regions of each subject), no gender-related differences were found
for any of the alkali metals. Also, no gender-related differences
were found in the alkalimetals levels at any individual brain region.
Although scarce, previous studies also showed no gender-related
differences on alkali metals levels in the human brain [28,35].
In a separate analysis by gender, the tendency for an age-
related increase ofNa levelswasonly observed for females (r = 0.56;
p=0.03), and was particularly significant in the hippocampus
(r = 0.61; p=0.01) and middle temporal gyrus (r = 0.66; p<0.001).
The tendency for an age-related decrease of Rb levels was still
present although not reaching statistical significance in both male
(r =−0.27; p=0.17) and female (r =−0.34; p=0.20). No age-related
changes were observed in either gender for the other alkali metals.
Also considering the mean metal levels, significantly higher
levels of K (15.4±5.1mg/g vs. 11.1±3.8mg/g; p =0.006),
Rb (15.2±5.0g/g vs. 11.1±3.8g/g; p =0.007) and Cs
(82.3±34.9ng/g vs. 61.9±21.3ng/g; p =0.034) were found in
smokers. The presence of alkali metals in tobacco has been
reported [43]. Higher levels of alkali metals in smokers could
be explained by the transference of these elements into tobacco
smoke and consequent absorption after inhalation. The transport
by the olfactory nerve directly to the brain is another potential
route of exposure [44]. Inhaled in cigarette smoke, nicotine quickly
reaches the brain. Chronic cigarette smoking has shown neuronal
membrane damage arising from decreased activity of membrane-
bound enzymes (e.g., Na+/K+-ATPase, Ca2+-ATPase, Mg2+-ATPase)
in rat brain [45] and reduced expression of functional Na+/K+-
ATPase at the blood-brain barrier [46]. Increased levels of K, Rb and
Cs found in brain tissue of smokers may be a result of a decreased
activity and/or expression of Na+/K+-ATPase, leading to imbalances
of electrolytes.
To our knowledge, no studies regarding the effect of smoking
habits in alkali metals levels in the human brain are available.
Disease-related changes on alkali metals levels
Besides elevated levels of reactive oxygen species and protein
aggregation, depressed Na+/K+-ATPase levels have been reported
in AD brain [47]. A decrease in Na+/K+-ATPase activity and protein
levels may lead to disturbances in the ionic equilibrium of neu-
ronal cells and play a role in the development of several disorders,
including ND such Alzheimer’s and Parkinson’s diseases [13].
Brain samples from two AD patients (73 and 85 years old) and
one PD patient (91 years old) were also obtained during the sample
collection period (first semester of 2012). Althoughno definite con-
clusions can be drawn with such a small number of cases, the ratio
between alkali metals levels in those patients and age-matched
control subjects are summarized in Table 3.
IncreasedNa levelswere found in the globus pallidus of both AD
patients, by a factor of 2.1 and 2.3, respectively. In AD#1 patient,
decreased K levels were found in 7 of the 14 brain regions, includ-
ing the medulla (4.9 vs. 9.2mg/g) and caudate nucleus (6.9 vs.
12.1mg/g). Although normal Rb and Cs levels were found in all of
the brain regions of AD#2, decreased levels of these elements were
found in most of the studied regions of the AD#1.
Regarding PD patient, increased Cs levels were found in 9 of the
14 brain regions by a factor ranging from 1.4-fold (in the superior
globus pallidus) to 16.7-fold (in the frontal cortex). Increased Rb
levelswerealso found inall thebrain regionsof this patient, ranging
from1.4-fold (in the cerebellum) to 2.4-fold (in the inferior parietal
lobe).
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Table 2
Levels (mass of element per mass of dry tissue weight) of alkali metals in the different human brain regions obtained in previous studies.
Ref  IT n  Age
(mean  ± sd;
range)
Brain  regions
1  2A  2B  3A  3B 3C  4 5 6 7 8  9  10  11
Cs [27]a NAA  4  (30–73)  149  ± 31
(ng/g) [28]a NAA  15  72 ± 13 38  ± 13
[29]a NAA  8  64 ± 19(38–87)  53.8  ± 21.5
[30]a NAA  1  5.13  4.61  5.68 4.56
[21]  NAA  5  75 60 ±  20  70  ± 20  60  ±  20  40 ±  10
[22]  NAA  5  57 ± 22 65  ±  23  59 ±  23  45  ±  20  44  ± 20
[31]  NAA  30  61(52–69)  73.9
[31]  NAA  30  63(55–72)  65.8
K [27]a NAA  4  (30–73)  7.69  ±  2.70
(mg/g) [28]a NAA  15  72 ± 13 12.77  ± 2.72
[29]a NAA  8  64 ± 19(38–87)  15.78  ±  3.93
[21]  NAA  5  75 11.8  ±  2.1  14.0  ± 1.3  11.8  ±  1.0  14.8 ±  1.6
[22]  NAA  5  10.73  ±  2.31 14.0  ± 1.53  11.82  ±  1.16  11.38  ±  3.86  13.99  ±  1.53
[31]  NAA  30  61(52–69)  17.29
[31]  NAA  30  63(55–72)  18.24
[20]  ICP-AES  3  14.3  ±  1.0  12.6  ±  1.0
[19]a ICP-AES  8  (50–60)  12.8  ± 1.7  14.9  ±  6.4  10.4  ± 4.3  19.3 ±  2.2 15.3  ±  4.3  11.2  ± 3.6  9.1  ± 4.0  10.9  ±  4.3  12.1  ± 2.8
[34]  NAA  21  79(51–94)  11.59  ± 1.36  12.01  ± 1.39
[23]  NAA  31  78 ± 9(51–95)  12.23  ± 1.30  13.34  ± 1.60  11.38  ±  1.64  12.87  ±  1.42  12.37  ±  1.24  15.87  ± 1.59
[25]  PIXE  12  36 ± 21(7–69)  16.8  ±  1.0  18.1  ±  1.5  15.3  ±  15.3  17.9  ± 1.9  17.0  ± 2.2  11.2  ±  2.0
Li(ng/g) [22]  ICP-AES  1  9.08  ±  0.51  7.80  ±  0.38
Na [27]a NAA  4  (30–73)  11.48  ± 4.84
(mg/g) [28]a NAA  15  72 ± 13 6.30  ± 1.19
[29]a NAA  8  64 ± 19(38–87)  8.94  ± 3.02
[21]  NAA  5  75 6.40  ±  0.50  5.00  ±  0.40  4.30  ±  0.30  10.2  ± 1.0
[22]  NAA  5  6.40  ±  0.57  4.98  ±  0.43  4.62  ±  0.30  8.62  ±  1.32  6.82  ± 0.39
[20]  ICP-AES  3  7.3  ±  0.8  12.2  ±  1.0
[19]a ICP-AES  8  (50–60)  8.5  ± 1.7  9.4  ±  3.0  11.2  ± 2.5  10.5  ± 1.7  10.5  ±  2.9 12.7  ± 6.9  7.6  ± 1.1  14.1  ±  5.1  7.7  ±  0.6
[34]  NAA  21  79(51–94)  8.67  ± 1.86  7.99 ±  1.43
[23]  NAA  31  78 ± 9(51–95)  7.96  ± 1.69  8.20  ± 1.35  7.51  ± 1.32  6.30  ± 1.09  6.02  ±  1.01  7.07  ± 0.94
[35]  ICP-AES  45  83 ± 8(70–101)  0.056  ±  0.043  0.052  ± 0.089  0.037  ±  0.026
[36]  ICP-AES  45  83 ± 8(70–101)  0.028  ± 0.05
Rb [25]  PIXE  12  36 ± 21(7–69)  18.4  ±  2.9  18.7  ±  2.9  15.7  ±  3.2  17.0  ± 2.6  15.1 ±  2.2 8.9 ±  1.7
(g/g) [37]a NAA  7  50  ± 19(23–60)  22.7  ±  1.3  26.3  ±  2.8  19.8  ±  1.2  21.1 ±  3.3 18.2  ±  4.5
[34]  NAA  21  79(51–94)  19.4  ± 5.1  21.6 ±  5.5
[38]  NAA  1  1.5  1.0  1.2  1.8  1.4  1.6
[27]a NAA  4  (30–73)  42.7  ±  11.3
[28]a NAA  15  72 ± 13 10.47  ±  2.77
[29]a NAA  8  64 ±19(38–87)  11.5  ± 4.35
[30]a NAA  1  12.3  8.5  8.1  6.4
[39]a ICP-MS  12  79 ± 9(63–89)  2.86 ±  0.87
[21]  NAA  5  75 14 ± 5  16  ±  6  14 ±  6 10 ±  4
[22]  NAA  5  15 ± 4  16  ±  6  13 ±  6 13  ±  6  12  ± 6
[31]  NAA  30  61(52–69)  7.73
[31]  NAA  30  63(55–72)  8.57
[23]  NAA  31  78 ± 9(51–95)  22.2  ± 5.2  21.6  ±  4.1  22.2  ± 5.2  23.2 ±  5.0  21.1  ±  3.7  24.5  ± 5.0
Brain regions: 1: frontal cortex; 2A: superior temporal gyrus; 2B: middle temporal gyrus; 3A: caudate nucleus; 3B: putamen; 3C: globus pallidus; 4: cingulated gyrus; 5: hippocampus; 6: inferior parietal lobule; 7: visual cortex
of  the occipital lobe; 8: midbrain; 9: pons; 10: medulla; 11: cerebellum.
a Results originally reported as per wet  weight basis. Converted into a dry weight basis by using dry to wet weight conversion ratios published for the specific brain regions [29,21,23,40].
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Fig. 3. Relationship between Na levels (mg/g) and age (years). Mean Na level (a) for each subject (mean value for the 14 brain regions) and Na levels in the hippocampus (b)
and middle temporal gyrus (c).
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Conclusion
This study, involving the direct determination of alkalimetals in
4 different brain regions of 42 non-diseased individuals, provides
vidence on the heterogeneous distribution of alkali metals across
he human brain: the lowest levels of K and Li were found in the
rainstem (midbrain,medulla and pons) and cerebellum,while thesubject (mean value for the 14 brain regions) and Rb levels in the hippocampus (b)
lowest levels of Cs were found in the frontal cortex. The highest
levels of K and Cs were found in putamen. Rubidium and Na seem
to bemore homogeneously distributed than the other alkalimetals.Considering the whole brain mean level, K, Cs and Li seem to
remain quite unchanged with age, but some age-related changes
were observed in Na and Rb levels in particular regions (namely in
the hippocampus).
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Fig. 5. Relationship between the mean value of K (mg/g) (a), Li (ng/g) (b) and Cs (ng/g) levels (c) in the 14 brain regions studied and age (years).
Table 3
Ratio between alkali metals levels in ND patients and age-matched control subjects.
Patient Element Brain regions
1 2A 2B 3A 3B 3C 4 5 6 7 8 9 10 11
AD#1 K 0.9 0.9 0.9 0.6 0.9 0.9 0.7 0.6 0.9 0.8 0.8 0.6 0.5 0.9
Na 1.0 1.3 1.2 1.2 1.0 2.1 1.3 1.0 1.3 0.9 1.0 0.9 0.7 0.8
Rb 0.7 0.7 0.8 0.6 0.8 0.7 0.5 0.6 0.7 0.7 0.7 0.5 0.7 0.8
Cs 0.3 0.3 0.3 1.5 0.4 1.4 0.6 0.9 0.3 0.4 0.4 0.5 1.0 0.1
Li 0.3 0.3 0.4 1.6 0.5 1.7 1.0 1.5 0.5 0.3 0.5 1.0 1.2 1.2
AD#2 K 1.2 0.9 1.0 1.1 1.1 1.0 1.2 1.1 1.1 1.1 1.1 1.2 1.6 1.0
Na 1.2 1.2 1.0 1.1 1.0 2.3 1.1 1.0 1.0 1.0 1.3 1.2 1.0 0.9
Rb 1.2 1.2 1.2 1.3 1.2 1.2 1.2 1.1 1.2 1.4 1.3 1.3 1.5 1.3
Cs 0.8 0.7 0.8 0.8 0.8 1.0 0.7 0.8 1.0 1.2 0.9 0.9 0.9 1.0
Li 1.1 1.0 1.4 1.1 0.8 1.1 1.5 1.1 1.5 1.1 1.8 1.3 1.4 0.7
PD K 1.1 1.3 1.0 0.6 1.0 1.1 1.2 1.1 1.3 0.9 1.0 1.0 1.0 0.9
Na 1.1 0.8 0.7 1.1 0.9 0.7 1.1 0.9 0.9 0.9 0.7 0.9 0.8 1.1
Rb 2.0 2.0 1.4 1.8 1.7 1.7 1.9 1.7 2.4 1.5 1.6 1.5 1.8 1.4
1.4
1.1
w
b
r
d
a
i
c
t
t
h
w
dCs 16.7 3.9 1.3 3.6 1.1
Li 14.2 2.4 1.4 5.3 0.9
No differences in alkali metals levels were found between
omen and men. Higher levels of K, Rb and Cs were found in the
rain of smokers compared to non-smokers.
Although differences in alkali metals levels in several brain
egions of ND patients were found, no conclusions can be drawn
ue to reduced number of diseased subjects.
This work provides comprehensive and updated data about
lkali metals levels in non-diseased human brain, thus contribut-
ng for defining the “normal” levels, in order to allow future
omparisons with data obtained from patients affected by ND. Fur-
hermore, thiswork showed that the distribution of alkalimetals in
he normal human brain is heterogeneous, namely for Li, Cs and K,
ighlighting the importance of defining the specific brain regions
hen studying the elemental composition on ND and other brain
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